KJIM :: Korean Journal of Internal Medicine

Predictors of Successful First-Line Helicobacter pylori Eradication with Fluoroquinolones in Pakistan: A Prospective Exploration of Demographic and Clinical Factors

Sumaira Khadim, Iyad Naeem Muhammad, Tanveer Alam, Shahnaz Usman, Hina Rehman, Sajjad Haider

Indications of Helicobacter pylori Eradication Treatment and Its Influence on Prescriptions and Effectiveness (Hp‐EuReg)

Samuel J. Martínez‐Domínguez, Olga P. Nyssen, Ángel Lanas, Enrique Alfaro, Laimas Jonaitis, Umud Mahmudov, Irina Voynovan, Babayeva Gülüstan, Luis Rodrigo, Giulia Fiorini, Ángeles Perez‐Aisa, Javier Tejedor‐Tejada, Bojan Tepes, Ludmila Vologzanina, Emin M

Sex differences in Helicobacter pylori infection and recurrence rate among 81,754 Chinese adults: a cross-sectional study

Yuqin Qiao, Yun Zhou, Li Zhao, Shengyi Yang, Xiaodong Zhang, Shixiong Liu

Progress on the Effect of Helicobacter pylori Eradication

Advances in Clinical Medicine.2023; 13(07): 11088. CrossRef

Efficacy and safety of triple therapy containing berberine, amoxicillin, and vonoprazan for Helicobacter pylori initial treatment: A randomized controlled trial

Shasha Chen, Weina Shen, Yuhuan Liu, Qiang Dong, Yongquan Shi

Chinese Medical Journal.2023; 136(14): 1690. CrossRef

Effective Eradication Regimen and Duration According to the Clarithromycin Susceptibility of Helicobacter pylori Determined Using Dual Priming Oligonucleotide-Based Multiplex Polymerase Chain Reaction

Soo-Young Na, Byung-Wook Kim, Min Ji Kim, Younghee Choe, Joon Sung Kim

Treatment of Helicobacter pylori infection 14‐day concomitant quadruple therapy versus triple therapy: A parallel double‐blind randomized controlled trial

Mohamed Hichem Loghmari, Firas Aissaoui, Arwa Guediche, Wided Bouhlel, Mejda Zakhama, Nabil B. Chaabene, Amel Rehaiem, Nouha Ben Abdeljalil, Manel Njima, Abdelfetteh Zakhama, Yosr Kadri, Maha Mastouri, Leila Safer

Helicobacter pylori Eradication Rate Using Stool Antigen Test in Vietnamese Children: A Prospective Multicenter Study

Tu Cam Nguyen, Annie Robert, Thu Hien Anh Pham, Khoa Hoang Vo, Loc Duc Le, Ha Tu Ma, My Huynh Thao Le, Thai Hoang Che, Hiep Thanh Nguyen, Dinh Quang Truong, Patrick Bontems, Phuong Ngoc Van Nguyen

Alcohol increases treatment failure for Helicobacter pylori eradication in Asian populations

Jing Yu, Yiming Lv, Peng Yang, Yizhou Jiang, Xiangrong Qin, Xiaoyong Wang

High incidence of antibiotic resistance amongst isolates of Helicobacter pylori collected in Nottingham, UK, between 2001 and 2018

Elizabeth Garvey, Joanne Rhead, Suffi Suffian, Daniel Whiley, Farah Mahmood, Naveen Bakshi, Darren Letley, Jonathan White, John Atherton, Jody Anne Winter, Karen Robinson

Journal of Medical Microbiology .2023;[Epub] CrossRef

Eradicate Helicobacter pylori first, or treat peptic ulcer disease?

Cost-Effectiveness of Empirical Bismuth-Based Quadruple Therapy and Tailored Therapy After Clarithromycin Resistance Tests for Helicobacter pylori Eradication

Young Woon Chang, Ga Young Shin, Jung-Wook Kim, Jin-Chang Moon, Eun Jee Chang, Chi Hyuk Oh, Jae-Young Jang

Digestive Diseases and Sciences.2022; 67(4): 1222. CrossRef

Management of Helicobacter Pylori Infection and Effectiveness Rates in Daily Clinical Practice in Spain: 2010–2019

Inés Ariño Pérez, Samuel J. Martínez-Domínguez, Enrique Alfaro Almajano, Patricia Carrera-Lasfuentes, Ángel Lanas

Eradication Rate Using a First-line Triple Therapy for Helicobacter pylori Infection in Yeongdong, Gangwon Province, Korea

Eun Jeong Gong, Chang Seok Bang, Myeongsook Seo, Hyun Il Seo, Jong Kyu Park, Sang Jin Lee, Koon Hee Han, Woo Jin Jeong, Young Don Kim, Gab Jin Cheon

The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2022; 22(2): 139. CrossRef

7‐day versus 14‐day tegoprazan‐based triple therapy to treat Helicobacter pylori infection: Real‐world evidence

Yoon Suk Jung, Sunyong Kim, Hyun‐Young Kim, Seung Jae Noh, Jung Ho Park, Chan Hyuk Park

Journal of Gastroenterology and Hepatology.2022; 37(10): 1911. CrossRef

Effects of CYP2C19 genetic polymorphisms on the cure rates of H. pylori in patients treated with the proton pump inhibitors: An updated meta-analysis

Xianghong Zhao, Zhongqiu Zhang, Fang Lu, Mengqiu Xiong, Liping Jiang, Ke Tang, Min Fu, Yu Wu, Bangshun He

Sex and Gender Differences in Bacterial Infections

Sara P. Dias, Matthijs C. Brouwer, Diederik van de Beek, Anthony R. Richardson

Comparative Efficacy of 14-Day Tegoprazan-Based Triple vs. 10-Day Tegoprazan-Based Concomitant Therapy for Helicobacter pylori Eradication

Chan Hyuk Park, Myung Jin Song, Byung Wook Jung, Jung Ho Park, Yoon Suk Jung

Journal of Personalized Medicine.2022; 12(11): 1918. CrossRef

COST-EFFECTIVENESS ANALYSIS OF GASTRITIS THERAPY IN AN AIR FORCE HOSPITAL IN BANDUNG, INDONESIA

RIANI TANJUNG, YULIA WARDATI, DINI NUR AZIZAH, BHEKTI PRATIWI, RESMI MUSTARICHIE, NYI MEKAR SAPTARINI

International Journal of Applied Pharmaceutics.2022; : 67. CrossRef

The efficacy of Helicobacter pylori eradication in diabetics and its effect on glycemic control: A systematic review and meta‐analysis

Xin Song, Changzhou Cai, Qi Jin, Xueyang Chen, Chaohui Yu

Prevalence of Helicobacter pylori Antimicrobial Resistance Among Chilean Patients

Patricio González-Hormazábal, Alex Arenas, Carolina Serrano, Margarita Pizarro, Eduardo Fuentes-López, Jorge Arnold, Zoltan Berger, Maher Musleh, Héctor Valladares, Enrique Lanzarini, Lilian Jara, V. Gonzalo Castro, M. Constanza Camargo, Arnoldo Riquelme

Archives of Medical Research.2021; 52(5): 529. CrossRef

The status and progress of first-line treatment against Helicobacter pylori infection: a review

Caiqi Liu, Yuan Wang, Jiaqi Shi, Chunhui Zhang, Jianhua Nie, Shun Li, Tongsen Zheng

Therapeutic Advances in Gastroenterology.2021;[Epub] CrossRef

Types of 23S Ribosomal RNA Point Mutations and Therapeutic Outcomes for Helicobacter pylori

Sang Yoon Kim, Jae Myung Park, Chul-Hyun Lim, Hye Ah Lee, Ga-Yeong Shin, Younghee Choe, Yu Kyung Cho, Myung-Gyu Choi

Molecular detection of genotypic clarithromycin‐resistant strains and its effect on the eradication rate of concomitant therapy in Helicobacter pylori infection

The Effect of CYP2C19 Gene Polymorphism on the Eradication Rate of Helicobacter Pylori by Proton Pump Inhibitors-ContAining Regimens in Asian Populations: a Meta-Analysis

Juan Fu, Chang-Feng Sun, Hong-Yan He, Suvash Chandra Ojha, Han Shi, Cun-Liang Deng, Yun-Jian Sheng

Host Genetic Determinants Associated With Helicobacter pylori Eradication Treatment Failure: A Systematic Review and Meta-analysis

Shailja C. Shah, Adam Tepler, Cecilia P. Chung, Giovanni Suarez, Richard M. Peek, Adriana Hung, Christianne Roumie, Neeraj Narula

Correlation between clarithromycin resistance, virulence factors and clinical characteristics of the disease in Helicobacter pylori infected patients in Shahrekord, Southwest Iran

Razieh Sadat Hosseini, Ghorbanali Rahimian, Mohammad Hadi Shafigh, Majid Validi, Mansoor Khaledi, Abolfazl Gholipour

Sex differences in the relationship among alcohol, smoking, and Helicobacter pylori infection in asymptomatic individuals

Wenzhi Wu, Marcis Leja, Vladislav Tsukanov, Zarrin Basharat, Dong Hua, Wandong Hong

Journal of International Medical Research.2020;[Epub] CrossRef

Efficacy of Seven-day High-dose Esomeprazole-based Triple Therapy versus Seven-day Standard Dose Non-esomeprazole-based Triple Therapy as the First-line Treatment of Patients with Helicobacter pylori Infection

Young Dal Lee, Sung Eun Kim, Seun Ja Park, Moo In Park, Won Moon, Jae Hyun Kim, Kyoungwon Jung, Jiyun Song

The Korean Journal of Gastroenterology.2020; 76(3): 142. CrossRef

First-line Helicobacter pylori Eradication Rate of the 10-day Hybrid Therapy

Jeong Hun Park, Dongwoo Kim, Jung Wan Choe, Seung Young Kim, Sung Woo Jung, Jong Jin Hyun, Young Kul Jung, Ja Seol Koo, Hyung Joon Yim, Sang Woo Lee

The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2020; 20(4): 300. CrossRef

Review – Treatment of Helicobacter pylori infection 2020

Anthony O'Connor, Takahisa Furuta, Javier P. Gisbert, Colm O'Morain